Newsletter
Newsletter Support JNS

Breakthrough in bringing COVID-19 vaccine to Israel

Prime Minister Benjamin Netanyahu says he’s removed bureaucratic impediments to inking a deal with pharmaceutical giant Pfizer.

Vials of the experimental COVID-19 vaccine from the Israel Institute for Biological Research. Credit: Israeli Defense Ministry Spokesperson's Office.
Vials of the experimental COVID-19 vaccine from the Israel Institute for Biological Research. Credit: Israeli Defense Ministry Spokesperson’s Office.

“Significant progress” was made late Wednesday night in removing bureaucratic impediments to signing a deal with pharmaceutical giant Pfizer to enable the import of the coronavirus vaccine to Israel, the Prime Minister’s Office stated on Thursday.

Israeli Prime Minister Benjamin Netanyahu spoke on the phone with Pfizer chairman and CEO Albert Bourla at 2 a.m. to iron out details of an agreement. To this end, he included Deputy Attorney General Roi Sheindorf and Pfizer’s legal adviser in the call.

The upshot of the conference call, the PMO said, is that a deal between the State of Israel and Pfizer will be signed in the coming days.

The news comes on the heels of Pfizer’s announcement on Monday that its COVID-19 vaccine has a 90 percent efficacy rate, which Netanyahu referred to as “an important day in the global struggle against coronavirus.”

Several other companies were making progress towards a vaccine, he said, including Israel, but still required more time.

Nevertheless, he added, “One thing is clear. Not long from today—it will not be years but months—there will be vaccines that will be available for the population of the world. My goal at the moment is to do one thing—bring vaccines to you, citizens of Israel, and we will do so. This means that the end is in view. I said a few days ago that I see light at the end of the tunnel. I think that train is already exiting the tunnel.”

With 85% of the expected vote counted, El-Sayed had received 2,206,235 votes, or 52%, compared with Republican Mike Rogers’s 1,952,991 votes, or 46%.
Unlike in the past, the Israeli president decided to start the meetings with smaller parties.
In response to a question shouted from the press pool, the president said he would not resume strikes on Iran after the election.
“Aiding Hamas would require not just a single collaborator, but an extensive network,” Herzi Halevi said. “Yet, even after three years, not a single such person has been found.”